Published in Nature on February 20, 1975
Stochastic mechanisms in gene expression. Proc Natl Acad Sci U S A (1997) 13.65
Mutagenesis of the three bases preceding the start codon of the beta-galactosidase mRNA and its effect on translation in Escherichia coli. EMBO J (1984) 1.94
Translational initiation frequency of atp genes from Escherichia coli: identification of an intercistronic sequence that enhances translation. EMBO J (1985) 1.67
Translational regulation: identification of the site on bacteriophage T4 rIIB mRNA recognized by the regA gene function. Proc Natl Acad Sci U S A (1981) 1.63
Translation of a synthetic two-cistron mRNA in Escherichia coli. Proc Natl Acad Sci U S A (1986) 1.40
Potential secondary structure at translation-initiation sites. Nucleic Acids Res (1987) 1.36
Subcellular distribution of viral structural proteins during simian virus 40 infection. J Virol (1984) 1.34
In the Escherichia coli lacZ gene the spacing between the translating ribosomes is insensitive to the efficiency of translation initiation. Nucleic Acids Res (1991) 1.00
Translation initiation controls the relative rates of expression of the bacteriophage lambda late genes. Proc Natl Acad Sci U S A (1988) 0.97
Posttranscriptional modulation of bacteriophage P22 scaffolding protein gene expression. J Virol (1985) 0.96
The control of lambda DNA terminase synthesis. Nucleic Acids Res (1987) 0.88
Fusions of bacteriophage P22 late genes to the Escherichia coli lacZ gene. J Virol (1987) 0.83
In polycistronic Qbeta RNA, single-strandedness at one ribosome binding site directly affects translational initiations at a distal upstream cistron. Nucleic Acids Res (2010) 0.75
Identification of ribosome binding sites in Escherichia coli using neural network models. Nucleic Acids Res (1995) 0.75
Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol (1999) 13.53
Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group. N Engl J Med (1999) 10.21
Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control (1999) 8.64
Enhancing the efficiency of DNA-mediated gene transfer in mammalian cells. Somatic Cell Genet (1981) 7.07
Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number. Am J Hum Genet (1997) 4.29
Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature (1986) 4.13
The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle. Nature (1988) 3.85
Health care for black and poor hospitalized Medicare patients. JAMA (1994) 3.74
Cloning of the breakpoint of an X;21 translocation associated with Duchenne muscular dystrophy. Nature (1986) 3.62
Protein degradation in E. coli: the lon mutation and bacteriophage lambda N and cII protein stability. Cell (1981) 3.58
Efficacy of control measures in preventing nosocomial transmission of multidrug-resistant tuberculosis to patients and health care workers. Ann Intern Med (1995) 3.31
Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy. Science (1988) 2.82
Information content and clarity of radiologists' reports for chest radiography. Acad Radiol (1996) 2.56
FGFR2 mutation associated with clinical manifestations consistent with Antley-Bixler syndrome. Am J Med Genet (1998) 2.56
A cDNA clone from the Duchenne/Becker muscular dystrophy gene. Nature (1987) 2.55
Dystrophin is localized to the plasma membrane of human skeletal muscle fibers by electron-microscopic cytochemical study. Muscle Nerve (1990) 2.41
Arm edema in breast cancer patients. J Natl Cancer Inst (2001) 2.35
Duplicational mutation at the Duchenne muscular dystrophy locus: its frequency, distribution, origin, and phenotypegenotype correlation. Am J Hum Genet (1990) 2.20
Guideline for infection control in healthcare personnel, 1998. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol (1998) 2.20
The role of adenosine 3',5'-cyclic monophosphate in the growth of bacteriophage lambda. Virology (1972) 2.08
Surgical-site complications associated with a morphine nerve paste used for postoperative pain control after laminectomy. Infect Control Hosp Epidemiol (1999) 2.03
Polymorphism of the 3' open reading frame of the virus associated with the acquired immune deficiency syndrome, human T-lymphotropic virus type III. Nucleic Acids Res (1985) 2.01
Somatic reversion/suppression in Duchenne muscular dystrophy (DMD): evidence supporting a frame-restoring mechanism in rare dystrophin-positive fibers. Am J Hum Genet (1992) 1.81
Evidence-based care for depression in managed primary care practices. Health Aff (Millwood) (1999) 1.68
Molecular and functional analysis of the muscle-specific promoter region of the Duchenne muscular dystrophy gene. Mol Cell Biol (1990) 1.64
Isolation of human cDNAs for asparagine synthetase and expression in Jensen rat sarcoma cells. Mol Cell Biol (1987) 1.61
Tumor development in the Beckwith-Wiedemann syndrome is associated with a variety of constitutional molecular 11p15 alterations including imprinting defects of KCNQ1OT1. Hum Mol Genet (2001) 1.58
Dystrophin is expressed in mdx skeletal muscle fibers after normal myoblast implantation. Am J Pathol (1989) 1.55
Age-related conversion of dystrophin-negative to -positive fiber segments of skeletal but not cardiac muscle fibers in heterozygote mdx mice. J Neuropathol Exp Neurol (1990) 1.53
Molecular analysis of a constitutional X-autosome translocation in a female with muscular dystrophy. Science (1987) 1.53
Mechanisms of tandem duplication in the Duchenne muscular dystrophy gene include both homologous and nonhomologous intrachromosomal recombination. EMBO J (1991) 1.53
Partial gene duplication in Duchenne and Becker muscular dystrophies. J Med Genet (1988) 1.50
Isolation and characterization of an alpha-amanitin-resistant rat myoblast mutant cell line possessing alpha-amanitin-resistant RNA polymerase II. J Biol Chem (1975) 1.49
Population genetic structure of a colonising, triploid weed, Hieracium lepidulum. Heredity (Edinb) (2004) 1.39
Human ribosomal RNA genes: orientation of the tandem array and conservation of the 5' end. Science (1988) 1.38
Direct-to-consumer genetic testing: good, bad or benign? Clin Genet (2009) 1.34
Characterization of translational frame exception patients in Duchenne/Becker muscular dystrophy. Hum Mol Genet (1993) 1.33
Differentiation of Duchenne and Becker muscular dystrophy phenotypes with amino- and carboxy-terminal antisera specific for dystrophin. Am J Hum Genet (1991) 1.30
Outcomes of patients with do-not-resuscitate orders. Toward an understanding of what do-not-resuscitate orders mean and how they affect patients. Arch Intern Med (1995) 1.21
Point mutation in the human dystrophin gene: identification through western blot analysis. Genomics (1991) 1.21
Identification of a novel TA-rich DNA binding protein that recognizes a TATA sequence within the brain creatine kinase promoter. Nucleic Acids Res (1988) 1.18
Evidence for post-transcriptional control of the morphogenetic genes of bacteriophage lambda. J Mol Biol (1974) 1.17
Evidence for mutation by unequal sister chromatid exchange in the Duchenne muscular dystrophy gene. Am J Hum Genet (1989) 1.17
Hunter disease (mucopolysaccharidosis type II) associated with unbalanced inactivation of the X chromosomes in a karyotypically normal girl. Am J Hum Genet (1991) 1.17
Does what nurses do affect clinical outcomes for hospitalized patients? A review of the literature. Health Serv Res (1999) 1.16
Isolation and sequence analysis of cDNA clones coding for rat skeletal muscle creatine kinase. J Biol Chem (1984) 1.15
Expression and amplification of engineered mouse dihydrofolate reductase minigenes. Mol Cell Biol (1983) 1.15
Insulin stimulates myogenesis in a rat myoblast line. Nature (1974) 1.14
Regulation of RNA polymerase II activity in a mutant rat myoblast cell line resistant to alpha-amanitin. Nature (1975) 1.12
Prenatal identification of a girl with a t(X;4)(p21;q35) translocation: molecular characterisation, paternal origin, and association with muscular dystrophy. J Med Genet (1990) 1.09
Dystrophin in frameshift deletion patients with Becker muscular dystrophy. Am J Hum Genet (1992) 1.09
Cloning and expression of rat histidase. Homology to two bacterial histidases and four phenylalanine ammonia-lyases. J Biol Chem (1990) 1.09
A novel dystrophin isoform is required for normal retinal electrophysiology. Hum Mol Genet (1995) 1.07
Molecular diagnosis of non-deletion SMA patients using quantitative PCR of SMN exon 7. Neurogenetics (1997) 1.06
Changes over time in the use of do not resuscitate orders and the outcomes of patients receiving them. Med Care (1997) 1.05
Molecular structure of the human asparagine synthetase gene. Genomics (1989) 1.04
Genetic linkage map of facioscapulohumeral muscular dystrophy and five polymorphic loci on chromosome 4q35-qter. Am J Hum Genet (1992) 1.04
Molecular deletion analysis in Duchenne muscular dystrophy. J Med Genet (1986) 1.02
Characterization of a deletion at Xq27-q28 associated with unbalanced inactivation of the nonmutant X chromosome. Am J Hum Genet (1992) 1.02
Caregiver and adult patient perspectives on the importance of a diagnosis of 22q11.2 deletion syndrome. J Intellect Disabil Res (2011) 1.01
Analysis of human blood monocyte activation at the level of gene expression. Expression of alpha interferon genes during activation of human monocytes by poly IC/LC and muramyl dipeptide. J Exp Med (1985) 0.99
Glycosphingolipids of clonal lines of mouse neuroblastoma and neuroblastoma X L cell hybrids. J Biol Chem (1973) 0.99
Autosomal recessive inheritance of vasopressin-resistant diabetes insipidus. Am J Med Genet (1991) 0.98
Duchenne/Becker muscular dystrophy: correlation of phenotype by electroretinography with sites of dystrophin mutations. Hum Genet (1999) 0.97
FRAXE expansion is not a common etiological factor among developmentally delayed males. Am J Hum Genet (1995) 0.97
Repression and autogenous stimulation in vitro by bacteriophage lambda repressor. Proc Natl Acad Sci U S A (1975) 0.96
Fine structure analysis of the Chinese hamster AS gene encoding asparagine synthetase. Gene (1989) 0.95
Amanitin binding to RNA polymerase II in alpha-amanitin-resistant rat myoblast mutants. J Mol Biol (1977) 0.95
Immunogold labelling of dystrophin in human muscle, using an antibody to the last 17 amino acids of the C-terminus. Neuromuscul Disord (1991) 0.94
Molecular analysis of X-autosome translocations in females with Duchenne muscular dystrophy. EMBO J (1991) 0.93
Linkage analysis of polymorphisms within the DNA fragment XJ cloned from the breakpoint of an X;21 translocation associated with X linked muscular dystrophy. J Med Genet (1986) 0.92
mdxCv3 mouse is a model for electroretinography of Duchenne/Becker muscular dystrophy. Invest Ophthalmol Vis Sci (1995) 0.92
Expression and synthesis of alternatively spliced variants of Dp71 in adult human brain. Neuromuscul Disord (2000) 0.92
Cloning and characterization of alternatively spliced isoforms of Dp71. Hum Mol Genet (1995) 0.92
Combined use of molecular and biomarkers for presymptomatic carrier risk assessment in familial adenomatous polyposis: implications for screening guidelines. Dis Colon Rectum (1994) 0.91
The clinical and genetic epidemiology of neuronal ceroid lipofuscinosis in Newfoundland. Clin Genet (2008) 0.90
Myogenic regulation of dystrophin gene expression. Br Med Bull (1989) 0.90
Characterization of the ocular phenotype of Duchenne and Becker muscular dystrophy. Ophthalmology (1994) 0.90
Myogenic differentiation of L6 rat myoblasts: evidence for pleiotropic effects on myogenesis by RNA polymerase II mutations to alpha-amanitin resistance. Mol Cell Biol (1983) 0.89
Familial Simpson-Golabi-Behmel syndrome: studies of X-chromosome inactivation and clinical phenotypes in two female individuals with GPC3 mutations. Clin Genet (2010) 0.89
Dystrophin is tightly associated with the sarcolemma of mammalian skeletal muscle fibers. Exp Cell Res (1991) 0.89
Inherited deletion at Duchenne dystrophy locus in normal male. Lancet (1987) 0.88
X linked spondyloepiphyseal dysplasia: a clinical, radiological, and molecular study of a large kindred. J Med Genet (1996) 0.88
A muscle-specific enhancer within intron 1 of the human dystrophin gene is functionally dependent on single MEF-1/E box and MEF-2/AT-rich sequence motifs. Nucleic Acids Res (1997) 0.88
Requirements for infrastructure and essential activities of infection control and epidemiology in out-of-hospital settings: a consensus panel report. Association for Professionals in Infection Control and Epidemiology and Society for Healthcare Epidemiology of America. Infect Control Hosp Epidemiol (1999) 0.87
Competence for DNA transfer of ouabain resistance and thymidine kinase: clonal variation in mouse L-cell recipients. Somatic Cell Genet (1981) 0.87
Tissue-specific methylation differences and cognitive function in fragile X premutation females. Am J Med Genet (1996) 0.87
Identification of a transcriptional enhancer within muscle intron 1 of the human dystrophin gene. Hum Mol Genet (1996) 0.87
Diagnosis of Duchenne and Becker muscular dystrophies by polymerase chain reaction. A multicenter study. JAMA (1992) 0.87
Molecular cloning of cDNA for rat argininosuccinate lyase and its expression in rat hepatoma cell lines. Mol Cell Biol (1986) 0.86
Properties of an unusual photoproduct of U.V. irradiated thymidylyl-thymidine. Photochem Photobiol (1965) 0.86
Downstream regulation of int gene expression by the b2 region in phage lambda. Gene (1981) 0.86
Identification of a novel actin binding site within the Dp71 dystrophin isoform. FEBS Lett (1998) 0.85
Paternal inheritance of translocation chromosomes in a t(X;21) patient with X linked muscular dystrophy. J Med Genet (1986) 0.85
Negative-configuration electroretinogram in Oregon eye disease. Consistent phenotype in Xp21 deletion syndrome. Arch Ophthalmol (1993) 0.84
New chromosome 11p15 epigenotypes identified in male monozygotic twins with Beckwith-Wiedemann syndrome. Cytogenet Genome Res (2006) 0.84
A grandpaternally derived de novo deletion within Xp21 initially presenting in carrier females diagnosed as Kugelberg-Welander syndrome. Am J Med Genet (1988) 0.84